Skip to main content
. 2022 Feb 21;11(1):616–628. doi: 10.1080/22221751.2022.2037393

Figure 6.

Figure 6.

Circulating and hepatic miR-192-3p expression are increased in CHB patients. (A) Distribution of serum miR-192-3p levels in HBeAg-positive or negative patients and healthy controls. Serum miR-192-3p level was measured by quantitative real-time RT-PCR analysis using specific primers. Correlation analyses of serum miR-192-3p levels and HBV DNA loads (B) or HBsAg levels (C) in CHB patients. (D) The hepatic miR-192-3p levels in CHB and healthy controls. *P < .05; **P < .01; ns, no significance.